Clinical Trials Logo

Analgesic Adverse Reaction clinical trials

View clinical trials related to Analgesic Adverse Reaction.

Filter by:

NCT ID: NCT03203967 Completed - Clinical trials for Total Knee Arthroplasty

Epidural Morphine for Postoperative Analgesia After Total Knee Arthroplasty

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

Single femoral nerve blockade combined with patient-controlled intravenous analgesia are used for postoperative analgesia for patients after TKA in the hospital of the investigators. Although this method provides acceptable analgesia, the incidence of opioid-associated side effects is relatively high. Low-dose epidural morphine is commonly used in postoperative analgesia after cesarean section, and the effect of single dose morphine lasts more than 20 hours, with low incidences of itching, nausea, vomiting, and respiratory depression. The investigators hypothesize that, for patients undergoing TKA, the addition of low-dose epidural morphine to single femoral nerve block and intravenous opioids can improve the postoperative analgesia, reduce the consumption of intravenous opioids and decrease opioid-associated side effects.

NCT ID: NCT02717637 Completed - Clinical trials for Analgesic Adverse Reaction

Oxycodone in Serum After Postoperative Oral Oxycodone in Caesarean Sections Under Spinal Anesthesia

Start date: February 2016
Phase: N/A
Study type: Observational

All patients undergoing an elective caesarean section under spinal anesthesia will, according to the hospital routines, receive 10 mg oxycodone slow-release tablet when arriving at our postoperative care unit (PACU). Blood samples will be taken at 0 hour, 1 hour, 2 and 6 hours after administration in order to investigate bioavailability.